operation include an assessment of any possible impact, both positive and negative, that the conduct of the proposed initiative might have upon the established venereal disease control program in the locality or localities in which the project will be undertaken? (5) Does the proposal include a comprehensive and realistic plan for the evaluation of the project, and specify the measures and instruments of measurement to be used? (6) Is

To be eligible for a grant under this Program, an applicant must be: (a) One of the following: (1) A public or private nonprofit university, four year college, or other institution offering undergraduate, graduate, or health professional degrees, with a traditionally high (more than 50 percent) minority student enrollment; (2) A public or private nonprofit two year

(3) Recognition as reflected by awards and other honors received from scientific and professional organizations; and (4) The need for the group to have included within its membership experts from various areas of specialization within relevant scientific or technical fields, or authorities knowledgeable in the various disciplines and fields related to the scientific areas under review. (c) Except as otherwise provided by law

purpose of expenditures of endowment fund income; and (4) The expenses and charges associated with the management of the endowment funds if such expenses and charges were paid from endowment fund income. (b) Retain records in accordance with 45 CFR 74.53. The endowment fund corpus, fund income, and fund expenditures must be reported over a 20-year period, and supporting records are to be retained for 3 years after the submission of the

(a) The regulations of this part apply to the award of grants to support programs for basic research and training directed towards understanding, assessing, and attenuating the adverse effects on human health resulting from exposure to hazardous substances, as authorized under section 311(a) of the Act (42 U.S.C. 9660(a)). The purpose of these programs is to carry out

or DDREF); and, the role of non-radiation risk factors (such as smoking history). 2Draft Report of the NCI-CDC Working Group to Revise the 1985 NIH Radioepidemiological Tables, May 31, 2000, p. 17-18, p. 22-23. (b) NIOSH-IREP will operate according to the same general protocol as IREP for the analysis of uncertainty. It will address the same possible sources of uncertainty affecting

(a) The certificate of approval shall contain a classification and a description of the respirator or combination of respirators for which it is issued, as provided in this part. (b) The certificate of approval shall specifically set forth any restrictions or limitations on the respirator's use in hazardous atmospheres. (c) Each certificate of approval shall be accompanied by the drawings and

erroneously determined to be medically associated with a WTC-related health condition, pursuant to §88.17(b). (b) A WTC Health Program member will be notified in writing by the WTC Health Program of a decertification decision, provided an explanation, as appropriate, for the decision, and provided information on how to appeal the decision. A WTC Health Program member whose WTC

The following evidentiary standards apply to findings made under this part. (a) Standard of proof. An institutional or HHS finding of research misconduct must be proved by a preponderance of the evidence. (b) Burden of proof. (1) The institution or HHS has the burden of proof for making a

§110.42. Amendments to previously filed Request Packages and the filing deadlines for such amendments are described in §110.46. (c) The benefits available to different categories of requesters are described in §110.30.

For purposes of this subpart: Act means the Social Security Act. Freedom of Information Act rules means the substantive mandatory disclosure provisions of the Freedom of Information Act, 5 U.S.C. 552 (including the exemptions from

) Adjustment or recovery of an incorrect payment (or only such part of an incorrect payment as may be determined to be inconsistent with the purposes of Title XVIII of the Act) against an individual who is without fault will be deemed to be against equity and good conscience if the incorrect payment was made for items and services that are not payable under section 1862(a)(1) or (a)(9) of the Act and if the determination that such payment was incorrect was made subsequent to the fifth year following the

existence of ESRD, or the need for dialysis, or in any other manner. (2) The prohibitions of paragraph (a) of this section do not prohibit a plan from paying benefits secondary to Medicare after the first 18 months of ESRD-based eligibility or entitlement. (b) Age. A GHP of an employer or employee organization of at least 20 employees— (1) May not take into account

Department of Justice, or any other Department or agency of the United States in connection with an advisory opinion request under the procedures set forth in this part is exempt from disclosure under 5 U.S.C. 552, and will not be made publicly available. (d) Documents submitted by the requestor to CMS in connection with a request for an advisory opinion are available to the

(a) CMS awards and administers Medicare integrity program contracts in accordance with acquisition regulations set forth at 48 CFR chapters 1 and 3, this subpart, all other applicable laws, and all applicable regulations. These requirements for awarding Medicare integrity program contracts are used as follows: (1) When entering into new contracts. (2) When entering into contracts that may result in

agreement with a State for the State to monitor and enforce compliance with the requirements specified in paragraph (b) of this section by an organization that has obtained a waiver under this subpart. [63 FR 25377, May 7, 1998]

by CMS on the matter. (2) A final determination to revoke remains in effect until CMS finds that the reason for the revocation has been removed and that there is reasonable assurance that it will not recur. (d) Effect of revocation when supplier or other party has a financial interest in another entity. Revocation of the party's right to accept assignment also applies to any corporation

where proprietary data or privileged information is used in the LCD process and a court seeks to obtain or require disclosure of any proprietary data or privileged information contained in the LCD record, CMS or the Department will seek to have a protective order issued for that information, as appropriate.

that the LCD is valid. If the Board reverses an ALJ decision dismissing a complaint or holding that an LCD is valid without requiring discovery or the taking of evidence, the Board remands to the ALJ and the LCD review continues. If the Board reverses an ALJ decision holding that an LCD is valid that is reached after the ALJ has completed discovery and the taking of evidence, the Board may remand the case to the ALJ for further proceedings, or the Board may find that the provision(s) of the

services must be reinstated if his whereabouts become known during the time he is eligible for services. [44 FR 17932, Mar. 29, 1979, as amended at 78 FR 42302, July 15, 2013]

evaluation of personal information; (5) Medical data, including diagnosis and past history of disease or disability; and (6) Any information received for verifying income eligibility and amount of medical assistance payments (see §435.940 through

(a) General requirements. The State must operate the MEQC pilot in accordance with this section and §§431.812 through 431.820, as well as other instructions established by CMS. (b) Review requirements. The State must conduct reviews for the MEQC pilot in